LNAI
Lunai Bioworks Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$12.32M
P/E Ratio
—
EPS
$-7.56
Beta
0.49
52W High
$4.19
52W Low
$0.15
50-Day MA
$0.37
200-Day MA
$1.24
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Lunai Bioworks Inc.
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. The company is headquartered in Los Angeles, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-12.46M |
| Operating Margin | 0.00% |
| Return on Equity | -366.40% |
| Return on Assets | -13.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.56 |
| Price-to-Book | 0.48 |
| Price-to-Sales (TTM) | 70327.55 |
| EV/Revenue | 93386.37 |
| EV/EBITDA | -7.37 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $36.27M |
| Float | $17.86M |
| % Insiders | 31.35% |
| % Institutions | 3.07% |
Data last updated: 4/29/2026